New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
Location: Switzerland
Total raised: $65M
Investors 3
| Date | Name | Website |
| 10.06.2025 | Jeito Capi... | jeito.life |
| 12.06.2025 | ALSA Ventu... | alsaventur... |
| 03.06.2025 | Ysios Capi... | ysioscapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.05.2025 | Series A | $65M | - |
Mentions in press and media 10
| Date | Title | Description |
| 06.03.2026 | Investments in women-led companies set a clear record | The Swiss Startup ecosystem is clearly male dominated. According to the Startupticker database, female CEOs accounted only for 15.3% of startup foundations from 2021 to 2025. However, this share has increased compared with earlier years, w... |
| 02.10.2025 | Life sciences companies make positive progress | At Synendos Therapeutics, topline results of the phase 1 clinical trial for its lead asset, SYT-510, a first-in-class inhibitor that modulates a newly identified drug target in the Endocannabinoid System that helps restore healthy brain fu... |
| 23.07.2025 | Three biotechs on the verge of launching potential treatments | Berlin Heals, a pioneer in bioelectric medicine for the treatment of heart failure, announced the publication of a new peer-reviewed study titled "Two-year outcomes of a cardiac microcurrent device in chronic heart failure: A first-in... |
| 26.05.2025 | ReproNovo: $65 Million Series A Raised For Advancing Reproductive Medicine And Women’s Health Therapies | ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, announced the closing of a $65 million Series A financing round. The funding round was led by Jeito Capital, co-led by AXA IM A... |
| 22.05.2025 | ReproNovo's $65 Million Leap: A New Dawn for Reproductive Health | In a world where fertility rates are slipping like sand through fingers, ReproNovo emerges as a beacon of hope. This Swiss HealthTech startup, founded in 2021, has just secured $65 million in Series A financing. The funding round, led by Je... |
| 22.05.2025 | Jeito Capital leads $65 million round in ReproNovo | Jeito Capital led a $65 million Series A investment in ReproNovo ReproNovo Founded: 2021 Headquarters: Lausanne, Vaud, Switzerland See full company profile "> , a biopharma company developing treatments for reproductive medicine and... |
| 21.05.2025 | Swiss HealthTech company ReproNovo raises €57 million to tackle declining fertility rates | Lausanne-based HealthTech startup ReproNovo, a company innovating treatments for reproductive medicine and women’s health, has secured a €57 million Series A financing round. The round was led by Jeito Capital, AXA IM and M Ventures, alongs... |
| 21.05.2025 | ReproNovo raises USD65 million to advance Phase II clinical trials | ReproNovo, founded in 2021, is developing novel approaches to address critical gaps in reproductive medicine and women’s health, including male and female infertility as well as uterine health. The company, led by a team with expertise in ... |
| 21.05.2025 | ReproNovo Raises $65M in Series A Financing | ReproNovo, a Lausanne, Switzerland-based company dedicated to developing treatments for reproductive medicine and women’s health, raised $65M in Series A funding. The round was led by Jeito Capital, co-led by AXA IM Alts and founding invest... |
| - | ReproNovo | “New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.” |